The function of the minor subset of T lymphocytes bearing the γδ T cell antigen receptor is uncertain. Although some γδ T cells react to microbial products, responsiveness has only rarely been demonstrated toward a bacterial antigen from a naturally occurring human infection. Synovial fluid lymphocytes from patients with Lyme arthritis contain a large proportion of γδ cells that proliferate in response to the causative spirochete, Borrelia burgdorferi. Furthermore, synovial γδ T cell clones express elevated and sustained levels of the ligand for Fas (APO-1, CD95) compared to αβ T cells, and induce apoptosis of Fashigh CD4+ synovial lymphocytes. The findings suggest that γδ T cells contribute to defense in human infections, as well as manifest an immunoregulatory function at inflammatory sites by a Fas-dependent process.
Skip Nav Destination
Article navigation
1 December 1996
Article Contents
Article|
December 01 1996
Apoptosis of Fashigh CD4+ Synovial T Cells by Borrelia-reactive Fas-ligandhigh γδ T Cells in Lyme Arthritis
Michael S. Vincent,
Michael S. Vincent
From the *Divisions of Immunobiology and Rheumatology, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405-0068; ‡Immunex Corporation, Seattle, Washington 98101; §Institute of Biochemistry, University of Lausanne, Swiss Institute for Cancer Research, Epalinges, Switzerland; ‖Division of Rheumatology and Connective Tissue Research, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903
Search for other works by this author on:
Karen Roessner,
Karen Roessner
From the *Divisions of Immunobiology and Rheumatology, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405-0068; ‡Immunex Corporation, Seattle, Washington 98101; §Institute of Biochemistry, University of Lausanne, Swiss Institute for Cancer Research, Epalinges, Switzerland; ‖Division of Rheumatology and Connective Tissue Research, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903
Search for other works by this author on:
David Lynch,
David Lynch
From the *Divisions of Immunobiology and Rheumatology, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405-0068; ‡Immunex Corporation, Seattle, Washington 98101; §Institute of Biochemistry, University of Lausanne, Swiss Institute for Cancer Research, Epalinges, Switzerland; ‖Division of Rheumatology and Connective Tissue Research, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903
Search for other works by this author on:
David Wilson,
David Wilson
From the *Divisions of Immunobiology and Rheumatology, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405-0068; ‡Immunex Corporation, Seattle, Washington 98101; §Institute of Biochemistry, University of Lausanne, Swiss Institute for Cancer Research, Epalinges, Switzerland; ‖Division of Rheumatology and Connective Tissue Research, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903
Search for other works by this author on:
Sheldon M. Cooper,
Sheldon M. Cooper
From the *Divisions of Immunobiology and Rheumatology, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405-0068; ‡Immunex Corporation, Seattle, Washington 98101; §Institute of Biochemistry, University of Lausanne, Swiss Institute for Cancer Research, Epalinges, Switzerland; ‖Division of Rheumatology and Connective Tissue Research, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903
Search for other works by this author on:
Jurg Tschopp,
Jurg Tschopp
From the *Divisions of Immunobiology and Rheumatology, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405-0068; ‡Immunex Corporation, Seattle, Washington 98101; §Institute of Biochemistry, University of Lausanne, Swiss Institute for Cancer Research, Epalinges, Switzerland; ‖Division of Rheumatology and Connective Tissue Research, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903
Search for other works by this author on:
Leonard H. Sigal,
Leonard H. Sigal
From the *Divisions of Immunobiology and Rheumatology, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405-0068; ‡Immunex Corporation, Seattle, Washington 98101; §Institute of Biochemistry, University of Lausanne, Swiss Institute for Cancer Research, Epalinges, Switzerland; ‖Division of Rheumatology and Connective Tissue Research, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903
Search for other works by this author on:
Ralph C. Budd
Ralph C. Budd
From the *Divisions of Immunobiology and Rheumatology, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405-0068; ‡Immunex Corporation, Seattle, Washington 98101; §Institute of Biochemistry, University of Lausanne, Swiss Institute for Cancer Research, Epalinges, Switzerland; ‖Division of Rheumatology and Connective Tissue Research, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903
Search for other works by this author on:
Michael S. Vincent
,
Karen Roessner
,
David Lynch
,
David Wilson
,
Sheldon M. Cooper
,
Jurg Tschopp
,
Leonard H. Sigal
,
Ralph C. Budd
From the *Divisions of Immunobiology and Rheumatology, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405-0068; ‡Immunex Corporation, Seattle, Washington 98101; §Institute of Biochemistry, University of Lausanne, Swiss Institute for Cancer Research, Epalinges, Switzerland; ‖Division of Rheumatology and Connective Tissue Research, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903
Address correspondence to Dr. Ralph C. Budd, Division of Immunology, The University of Vermont College of Medicine, Given Medical Building Room C-303, Burlington, VT 05405-0068.
This work was supported by National Institutes of Health grant AR43520 and the Arthritis Foundation.
1Abbreviation used in this paper: PBL, peripheral blood lymphocytes.
Received:
May 22 1996
Revision Received:
September 09 1996
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1996
J Exp Med (1996) 184 (6): 2109–2118.
Article history
Received:
May 22 1996
Revision Received:
September 09 1996
Citation
Michael S. Vincent, Karen Roessner, David Lynch, David Wilson, Sheldon M. Cooper, Jurg Tschopp, Leonard H. Sigal, Ralph C. Budd; Apoptosis of Fashigh CD4+ Synovial T Cells by Borrelia-reactive Fas-ligandhigh γδ T Cells in Lyme Arthritis. J Exp Med 1 December 1996; 184 (6): 2109–2118. doi: https://doi.org/10.1084/jem.184.6.2109
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement